Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM)
Published inClinical Rheumatology, vol. 36, no. 1, p. 59-66
Publication date2017
Abstract
Keywords
- Adult
- Aged
- Antirheumatic Agents/therapeutic use
- Arthritis, Rheumatoid/drug therapy
- Biological Products/therapeutic use
- Disease Progression
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Glucocorticoids/therapeutic use
- Humans
- Male
- Middle Aged
- Prospective Studies
- Registries
- Severity of Illness Index
- Surveys and Questionnaires
- Switzerland
Affiliation
Research group
Citation (ISO format)
MUELLER, Ruediger B et al. Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM). In: Clinical Rheumatology, 2017, vol. 36, n° 1, p. 59–66. doi: 10.1007/s10067-016-3468-6
Main files (1)
Article (Published version)
Identifiers
- PID : unige:110910
- DOI : 10.1007/s10067-016-3468-6
- PMID : 27838788
ISSN of the journal0770-3198